Status:

COMPLETED

Move to Improve Physical Activity in Parkinson's Disease

Lead Sponsor:

University of Pennsylvania

Conditions:

Parkinson Disease

Apathy

Eligibility:

All Genders

Phase:

NA

Brief Summary

Apathy is a multi-dimensional behavior characterized by impairments to motivation, planning and initiation; collectively called, goal-directed behavior. It is highly prevalent in patients suffering fr...

Eligibility Criteria

Inclusion

  • Eligible participants will have a diagnosis of Parkinson's disease, and may have either normal cognition or mild cognitive impairment (MCI). Most eligible participants will have to have smartphones with wifi, application, Bluetooth, and text messaging capabilities. The study team does have five smart phone that can be provided to participants who do not have smartphones so as to not exclude these individuals.
  • Eligible participants will have to be mobile as the primary outcome measure for the study is step goals measured on the Fitbit. Participants will be eligible if they can ambulate successfully with a cane.
  • Participants will also need a study partner to be eligible to participant. This partner can be anyone of the eligible participant's choosing, who also consents to participation in the study.

Exclusion

  • Individuals will be excluded if they screen positive for dementia at the screening visit or do not have the decisional capacity to give consent. Dementia will be defined as a Montreal Cognitive Assessment (MoCA) score of \<22. Decisional capacity will be tested based on their understanding of study risks and benefits.
  • Individuals will also be excluded if they require a wheelchair or walker, or are unable to ambulate safely.
  • Individuals will be excluded if they are currently participating in another physical activity study, have been told by a physician not to exercise, or are currently pregnant.

Key Trial Info

Start Date :

August 26 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2023

Estimated Enrollment :

84 Patients enrolled

Trial Details

Trial ID

NCT04051151

Start Date

August 26 2019

End Date

December 1 2023

Last Update

January 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania's Parkinson's Disease and Movement Disorder Center

Philadelphia, Pennsylvania, United States, 19104